A detailed history of True Mark Investments, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, True Mark Investments, LLC holds 2,069 shares of LLY stock, worth $1.56 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
2,069
Previous 2,271 8.89%
Holding current value
$1.56 Million
Previous $2.06 Billion 10.85%
% of portfolio
0.59%
Previous 0.7%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $155,972 - $193,924
-202 Reduced 8.89%
2,069 $1.83 Billion
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $1.65 Million - $2.06 Million
2,271 New
2,271 $2.06 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track True Mark Investments, LLC Portfolio

Follow True Mark Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Mark Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Mark Investments, LLC with notifications on news.